Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.21.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Shares
Common Shares
Additional Paid in Capital
Accumulated Deficit
NonControlling Interest
Total
Beginning balance, shares at Dec. 31, 2018 1,260 2,979        
Beginning balance, amount at Dec. 31, 2018 $ 2 $ 22 $ 540,200 $ (528,685) $ (169) $ 11,370
Issuance of common stock for preferred stock, shares 1,190          
Issuance of common stock for preferred stock, amount $ 1   1,139     1,140
Common shares issued upon conversion of notes, shares   205        
Common shares issued upon conversion of notes, amount   $ 3 1,357     1,360
Beneficial conversion feature on convertible notes     158     158
Issuance of common stock for compensation, shares   921        
Issuance of common stock for compensation, amount   $ 16 5,293     5,309
Net loss (38,647) (38,647)
Ending balance, shares at Dec. 31, 2019 2,450 4,105        
Ending balance, amount at Dec. 31, 2019 $ 3 $ 41 548,147 (567,332) (169) (19,310)
Net loss           (19,130)
Ending balance, amount at Jun. 30, 2020           (27,499)
Beginning balance, shares at Dec. 31, 2019 2,450 4,105        
Beginning balance, amount at Dec. 31, 2019 $ 3 $ 41 548,147 (567,332) (169) (19,310)
Net loss           (22,006)
Ending balance, amount at Sep. 30, 2020           (29,777)
Beginning balance, shares at Dec. 31, 2019 2,450 4,105        
Beginning balance, amount at Dec. 31, 2019 $ 3 $ 41 548,147 (567,332) (169) (19,310)
Fair value of amended convertible notes and warrants     8,643     8,643
Issuance of common shares and warrants for settlement of litigation, shares   262        
Issuance of common shares and warrants for settlement of litigation, amount   $ 10 2,236     2,246
Common shares issued upon conversion of notes, shares   512        
Common shares issued upon conversion of notes, amount   $ 1 1,740     1,741
Beneficial conversion feature on convertible notes     5,274     5,274
Common shares issued upon exercise of warrants, shares   240        
Common shares issued upon exercise of warrants, amount           0
Issuance of common stock for compensation, shares   99        
Issuance of common stock for compensation, amount     269     269
Net loss (28,296) (28,296)
Ending balance, shares at Dec. 31, 2020 2,450 5,218        
Ending balance, amount at Dec. 31, 2020 $ 3 $ 52 $ 566,309 $ (595,628) $ (169) (29,433)
Beginning balance, amount at Jun. 30, 2020           (27,499)
Net loss           (11,519)
Ending balance, amount at Sep. 30, 2020           $ (29,777)